We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+9%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$24.5B
AUM Growth
+$4.37B
Cap. Flow
+$2.47B
Cap. Flow %
10.08%
Top 10 Hldgs %
39.35%
Holding
397
New
164
Increased
36
Reduced
47
Closed
100

Top Buys

Rank Stock Value
1
NUAN
Nuance Communications, Inc.
NUAN
+$387M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$332M
3
NOW icon
ServiceNow
NOW
+$265M
4
NYT icon
New York Times
NYT
+$189M
5
MXIM
Maxim Integrated Products
MXIM
+$152M

Top Sells

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$456M
2
IPHI
INPHI CORPORATION
IPHI
+$311M
3
IQV icon
IQVIA
IQV
+$278M
4
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$277M
5
EDU icon
New Oriental
EDU
+$192M

Sector Composition

Rank Sector Weight
1 Healthcare 29.51%
2 Technology 16.43%
3 Financials 13.12%
4 Communication Services 9.43%
5 Industrials 7.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KURA icon
176
Kura Oncology
KURA
$1.06B
$4.17M 0.02%
200,000
-200,000
-50% -$4.97M
VPCB
177
DELISTED
VPC Impact Acquisition Holdings II Class A ordinary shre
VPCB
$4.16M 0.02%
+425,000
New +$4.17M
GIIX
178
DELISTED
Gores Holdings VIII, Inc. Class A Common Stock
GIIX
$3.97M 0.02%
+400,000
New +$3.97M
CCVI
179
DELISTED
Churchill Capital Corp VI
CCVI
$3.94M 0.02%
+400,000
New +$3.97M
NDAC
180
DELISTED
NightDragon Acquisition Corp. Class A Common stock
NDAC
$3.9M 0.02%
+400,000
New +$3.92M
GETR
181
DELISTED
Getaround, Inc.
GETR
$3.88M 0.02%
+400,000
New +$3.91M
IPVF
182
DELISTED
InterPrivate III Financial Partners Inc.
IPVF
$3.88M 0.02%
+400,000
New +$3.9M
FRSG
183
DELISTED
First Reserve Sustainable Growth Corp. Class A Common Stock
FRSG
$3.88M 0.02%
+400,000
New +$3.9M
TPGS
184
DELISTED
TPG Pace Solutions Corp.
TPGS
$3.49M 0.01%
+350,000
New +$3.52M
TNGX icon
185
Tango Therapeutics
TNGX
$4.03B
$3.41M 0.01%
+300,000
New +$3.37M
GRFS
186
Grifois
GRFS
$5.44B
$3M 0.01%
172,738
-529,372
-75% -$9.48M
LGV
187
DELISTED
Longview Acquisition Corp. II
LGV
$2.99M 0.01%
+304,698
New +$3M
LGAC
188
DELISTED
Lazard Growth Acquisition Corp. I Ordinary Shares
LGAC
$2.93M 0.01%
+300,000
New +$2.95M
EMBK
189
DELISTED
Embark Technology, Inc. Common Stock
EMBK
$2.77M 0.01%
13,901
– –
FNCH
190
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
$2.61M 0.01%
6,178
-6,822
-52% -$2.95M
GTPA
191
DELISTED
Gores Technology Partners, Inc. Class A Common Stock
GTPA
$2.51M 0.01%
+250,000
New +$2.49M
DGNU
192
DELISTED
Dragoneer Growth Opportunities Corp. III Class A Ordinary Shares
DGNU
$2.5M 0.01%
250,000
– –
SVFA
193
DELISTED
SVF Investment Corp. Class A Ordinary Shares
SVFA
$2.47M 0.01%
250,000
– –
LOKM
194
DELISTED
Live Oak Mobility Acquisition Corp.
LOKM
$2.45M 0.01%
+250,000
New +$2.45M
HIII
195
DELISTED
Hudson Executive Investment Corp. III Class A Common Stock
HIII
$2.44M 0.01%
+250,000
New +$2.45M
CVA
196
DELISTED
Covanta Holding Corporation
CVA
$2.02M 0.01%
+115,000
New +$1.75M
ANAC
197
DELISTED
Arctos NorthStar Acquisition Corp.
ANAC
$1.95M 0.01%
+200,000
New +$1.96M
RGTI icon
198
Rigetti Computing
RGTI
$5.98B
$1.94M 0.01%
+200,000
New +$1.96M
CEREW
199
DELISTED
Cerevel Therapeutics Holdings, Inc. Warrant
CEREW
$1.91M 0.01%
134,175
– –
DCRCW
200
DELISTED
Decarbonization Plus Acquisition Corporation III Warrant
DCRCW
$1.69M 0.01%
+666,666
New +$1.28M
6 7
8
9 10

Similar funds

BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Thomas Steyer's Q2 2021 Portfolio in Review

As of Q2 2021, Thomas Steyer held 397 positions worth $24.5B, up 22% from $20.1B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Thomas Steyer deployed $2.47B of net new capital in Q2 2021, opening 164 new positions and adding to 36 existing holdings. Its largest new stake was Nuance Communications, Inc.: 7,337,500 shares worth $399M.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 36% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $456M trimmed.

  • Thomas Steyer's largest Q2 2021 buy was Nuance Communications, Inc.: 7,337,500 shares worth $399M.
  • Thomas Steyer added most to Alexion Pharmaceuticals in Q2 2021, an estimated $332M increase.
  • Thomas Steyer's biggest Q2 2021 reduction was Alphabet (Google) Class C, cutting an estimated $456M.
  • Thomas Steyer fully exited INPHI CORPORATION in Q2 2021, selling an estimated $311M.
  • Thomas Steyer's ten largest holdings make up 39% of its $24.5B portfolio in Q2 2021.
  • Thomas Steyer opened 164 new positions and closed 100 in Q2 2021.
  • Thomas Steyer's portfolio value rose 22% quarter-over-quarter to $24.5B.

Based on Farallon Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.